Forest Investigative Site 1107 — Augusta, Kansas

Forest Investigative Site 1107 is a clinical research site located in Augusta, Kansas, United States 67010.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1107 has participated in 1 clinical trials.

Therapeutic areas: Stage 1 Hypertension, Stage 2 Hypertension.

Sponsors: Forest Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Augusta

Browse all research sites in Kansas · View every site in Augusta

• Heartland Research Associates
• GSK Investigational Site
• Augusta Family Practice
• Synergy Research Site
• Heartland Research Associates LLC - Augusta
• Forest Investigative Site 025
• Influence Study Site
• Shionogi Research Site
• Research Site US038
• Site US00104
• 209, Novartis Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1107?

Forest Investigative Site 1107 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1107 conducted?

Forest Investigative Site 1107 has 1 clinical trials on record. Their work covers Stage 1 Hypertension, Stage 2 Hypertension.

Is Forest Investigative Site 1107 accredited by Crixeo Clinical Trials?

Forest Investigative Site 1107 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1107?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.